ROCK1 as a potential therapeutic target in osteosarcoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma is the most common primary bone cancer.
• Current treatments involving surgery and chemotherapy often lead to relapse.
• Recurrent osteosarcoma has limited and largely unsuccessful treatment options.

Purpose of the Study:

• To investigate the role of Rho-associated coiled-coil containing protein kinase 1 (ROCK1) in osteosarcoma.
• To determine if ROCK1 is a potential therapeutic target for osteosarcoma.

Main Methods:

• Screening of lentiviral shRNA libraries to identify kinases involved in osteosarcoma cell growth.
• Assessing ROCK1 expression in osteosarcoma cell lines and patient tissues via immunohistochemistry.
• Evaluating the effects of ROCK1 knockdown using synthetic small interfering RNA (siRNA) on osteosarcoma cell proliferation, viability, and apoptosis.

Main Results:

• ROCK1 is highly expressed in osteosarcoma cell lines and patient tumor tissues.
• ROCK1 knockdown significantly decreased osteosarcoma cell proliferation and viability.
• ROCK1 knockdown induced apoptosis in osteosarcoma cell lines (KHOS and U-2OS).
• High ROCK1 expression levels correlated with poor clinical prognosis and reduced overall survival in osteosarcoma patients.

Conclusions:

• ROCK1 plays a significant role in osteosarcoma cell proliferation and survival.
• Knockdown of ROCK1 demonstrates anti-cancer effects in osteosarcoma cells.
• ROCK1 represents a promising therapeutic target for improving outcomes in osteosarcoma patients.